Pregnant women and over 75s are being encouraged to take part in a new vaccination programme to protect themselves and unborn ...

The volume of recent flu infections and related hospitalizations is higher than what Sonoma County epidemiologists have ...

Dr. Michael Reihart, with Penn State Health, also explained who's most at risk for severe illness and how effective this year's vaccine is.

Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...

Here are four more respiratory illness updates: Nearly 1.7% of all deaths nationwide were attributed to flu, compared to approximately 1.5% from COVID-19. Influenza test positivity rose to 31.6%, ...

Dr. Smith is the president of the Tennessee Chapter of the American Academy of Pediatrics.

The U.S. has seen earlier and more intense surges of the flu and RSV this year than is typical, pediatrician Dr. Ryan Fulton ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

The flu just won’t quit this year. The virus seemed to peak after the December holidays in Massachusetts, headed back down, ...

Flu cases in the U.S. are peaking for a second time this winter, and according to one indicator, the current spike is the highest in 15 years. Last week’s percentage of doctor’s office visits driven ...

RSV season is in full swing, according to doctors at Children’s Hospital Colorado. Denver7 spoke with a local family that is all too familiar with the infection.

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...